A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study Meeting Abstract

  

Authors:	Bae-Jump, V. L.; Sill, M.; Gehrig, P. A.; Moxley, K.; Hagemann, A. R.; Waggoner, S. E.; O'Cearbhaill, R. E.; McDonald, M.; DiSilvestro, P. A.; Sperduto, P.; Aghajanian, C.
Abstract Title:	A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study
Meeting Title:	51st Annual Meeting of the Society of Gynecologic Oncology (SGO)
Journal Title:	Gynecologic Oncology
Volume:	159
Issue:	Suppl. 1
Meeting Dates:	2020 Mar 28-31
Meeting Location:	Toronto, Canada
ISSN:	0090-8258
Publisher:	Elsevier Inc.
Date Published:	2020-10-01
Start Page:	7
Language:	English
ACCESSION:	WOS:000579556200012
DOI:	10.1016/j.ygyno.2020.06.013
PROVIDER:	wos
Notes:	Meeting Abstract: LBA 11 -- This meeting was cancelled due to COVID-19 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/173872